Cigna Group Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cigna Corporation on April 28, 2022. The filing discloses the entry into new material definitive agreements regarding the company's credit facilities.
Key Financial Metrics and Debt Structure
The filing details the establishment of three new revolving credit facilities totaling $5.0 billion in initial commitments, replacing all existing revolving credit facilities:
- Five-Year Revolving Credit Agreement: $3.0 billion
- Three-Year Revolving Credit Agreement: $1.0 billion
- 364-Day Revolving Credit Agreement: $1.0 billion
The agreements include an option to increase commitments by an aggregate of up to $1.5 billion, allowing for a maximum total commitment of $6.5 billion. Interest rates are based on either the base rate or the secured overnight funding rate, plus an applicable margin tied to Cigna's senior unsecured credit ratings.
Material Changes and Covenants
The primary material change is the replacement of the company's prior revolving credit facilities with the new Credit Agreements. The agreements impose a financial covenant limiting the leverage ratio (total consolidated debt to total consolidated capitalization) to a maximum of 0.60 to 1.00. This threshold may be increased to 0.65 to 1.00 for the four quarters following an acquisition with cash consideration of $1.0 billion or more. The leverage calculation excludes net unrealized appreciation in fixed maturity investments and specific pension liability adjustments.
Outlook, Risks, and Contingencies
The Credit Agreements contain customary events of default, including bankruptcy, insolvency, change of control, and cross-acceleration with other debt agreements. A default could result in the termination of commitments and acceleration of repayment. The filing does not provide specific revenue, profit, or cash flow guidance for the reporting period, as the document focuses solely on the financing arrangement.
Key Facts for Investor Verification
- Verify the current utilization of the new $5.0 billion credit facilities.
- Confirm Cigna's current senior unsecured credit ratings to determine the applicable interest rate margins.
- Monitor the company's leverage ratio to ensure compliance with the 0.60 to 1.00 covenant threshold.
- Review the full text of the Revolving Credit and Letter of Credit Agreement (Exhibit 10.1) for detailed terms.